{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:10:44Z","timestamp":1791259844971,"version":"4.1.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Although interstitial lung disease (ILD) is a major cause of morbidity and mortality in systemic sclerosis (SSc), its prognostication remains challenging. Given that CT represents the gold standard imaging technique in ILD assessment, a systematic review on chest CT findings as predictors of mortality or ILD progression in SSc-ILD was performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>Three databases (Medline, Embase, and Web of Science) were searched to identify all studies analyzing CT mortality or ILD progression predictors in SSc-ILD, from inception to December 2020. ILD progression was defined by worsening of forced vital capacity and\/or CT ILD findings. Manuscripts not written in English, with not available full-text, not focusing on SSc-ILD or with SSc-ILD not extrapolated, otherwise with overlap syndromes, pediatric patients, &amp;lt;10 cases or predictors other than CT features were excluded.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Out of 3,513 citations, 15 full-texts (2,332 patients with SSc-ILD) met the inclusion criteria. ILD extent and extensive ILD, ILD densitometric analysis parameters, fibrotic extent and reticulation extent resulted as independent mortality predictors. Extensive ILD is also an independent predictor of death, need for supplemental oxygen or lung transplantation. Honeycombing extent is an independent risk factor for respiratory mortality. Independent predictors of ILD progression were not identified.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>ILD extent and extensive ILD independently predict mortality in SSc-ILD on CT, as well as ILD densitometric analysis, fibrotic extent and reticulation extent. Extensive ILD is also a predictor of death, need for supplemental oxygen, or lung transplantation. Honeycombing extent predicts respiratory mortality. CT predictors of ILD progression need to be further investigated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic Review Registration<\/jats:title><jats:p><jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero\/<\/jats:ext-link>, PROSPERO, identifier: CRD420202005001.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2021.807982","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T15:28:36Z","timestamp":1643297316000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Computed Tomography Predictors of Mortality or Disease Progression in Systemic Sclerosis\u2013Interstitial Lung Disease: A Systematic Review"],"prefix":"10.3389","volume":"8","author":[{"given":"Nicholas","family":"Landini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosimo","family":"Bruni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Carlesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosimo","family":"Nardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Calistri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Morana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Tomassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Colagrande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Matucci-Cerinic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12931-020-01459-0","article-title":"The need for a holistic approach for SSc-ILD \u2013 achievements and ambiguity in a devastating disease","volume":"21","author":"Hoffmann-Vold","year":"2020","journal-title":"Respir Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/2397198320915042","article-title":"Update on morbidity and mortality in systemic sclerosis-related interstitial lung disease","volume":"6","author":"Volkmann","year":"2021","journal-title":"J Scleroderma Relat Disord."},{"key":"B3","first-page":"3","article-title":"Review one year in review 2020: systemic sclerosis","volume":"125","author":"Orlandi","year":"2020","journal-title":"Clin Exp Rheumatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/BOR.0000000000000592","article-title":"Management of systemic sclerosis-associated interstitial lung disease","volume":"31","author":"Roofeh","year":"2019","journal-title":"Curr Opin Rheumatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1016\/S2665-9913(19)30144-4","article-title":"The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements","volume":"2","author":"Hoffmann-Vold","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1148\/rg.321105058","article-title":"Thoracic manifestations of collagen vascular diseases","volume":"32","author":"Capobianco","year":"2012","journal-title":"RadioGraphics."},{"key":"B7","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1378\/chest.13-2626","article-title":"Predictors of mortality and progression in scleroderma-associated interstitial lung disease","volume":"146","author":"Winstone","year":"2014","journal-title":"Chest."},{"key":"B8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.resinv.2012.12.002","article-title":"Effect of glucocorticoid monotherapy on pulmonary function and survival in Japanese patients with scleroderma-related interstitial lung disease","volume":"51","author":"Ando","year":"2013","journal-title":"Respir Investig."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e000820","DOI":"10.1136\/rmdopen-2018-000820","article-title":"Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosis","volume":"5","author":"Ariani","year":"2019","journal-title":"RMD Open."},{"key":"B10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.semarthrit.2018.10.011","article-title":"Combined pulmonary fibrosis and emphysema in systemic sclerosis: a syndrome associated with heavy morbidity and mortality","volume":"49","author":"Champtiaux","year":"2019","journal-title":"Semin Arthritis Rheum."},{"key":"B11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1752-699X.2010.00228.x","article-title":"Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease: scleroderma interstitial lung disease","volume":"6","author":"De Santis","year":"2012","journal-title":"Clin Respir J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.semarthrit.2020.02.015","article-title":"Evolution of high-resolution CT-scan in systemic sclerosis-associated interstitial lung disease: description and prognosis factors","volume":"50","author":"Forestier","year":"2020","journal-title":"Semin Arthritis Rheum."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/art.40130","article-title":"Short-term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis","volume":"69","author":"Goh","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1097\/00004728-200109000-00015","article-title":"Interstitial pneumonia in progressive systemic sclerosis: serial high-resolution CT findings with functional correlation","volume":"25","author":"Kim","year":"2001","journal-title":"J Comput Assist Tomogr."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e0181692","DOI":"10.1371\/journal.pone.0181692","article-title":"Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease","volume":"12","author":"Le Gouellec","year":"2017","journal-title":"PLoS ONE."},{"key":"B17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/rheumatology\/kes289","article-title":"Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease","volume":"52","author":"Moore","year":"2013","journal-title":"Rheumatology."},{"key":"B18","first-page":"S111","article-title":"Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease","volume":"33","author":"Moore","year":"2015","journal-title":"Clin Exp Rheumatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1513\/AnnalsATS.201910-741OC","article-title":"Association of computed tomography densitometry with disease severity, functional decline, and survival in systemic sclerosis-associated interstitial lung disease","volume":"17","author":"Saldana","year":"2020","journal-title":"Ann Am Thorac Soc."},{"key":"B20","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00296-017-3916-x","article-title":"Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group","volume":"38","author":"S\u00e1nchez-Cano","year":"2018","journal-title":"Rheumatol Int."},{"key":"B21","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/resp.13175","article-title":"Radiographic fibrosis score predicts survival in systemic sclerosis-associated interstitial lung disease: Radiographic fibrosis in SSc-ILD","volume":"23","author":"Takei","year":"2018","journal-title":"Respirology."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1007\/s10067-020-05105-4","article-title":"Progressive lung fibrosis and mortality can occur in early systemic sclerosis patients without pulmonary abnormalities at baseline assessment","volume":"39","author":"Vanaken","year":"2020","journal-title":"Clin Rheumatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). subcommittee for Scleroderma criteria of the American rheumatism association diagnostic and therapeutic criteria committee","volume":"23","author":"Masi","year":"1980","journal-title":"Arthritis Rheum."},{"key":"B24","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12916-016-0739-7","article-title":"Evaluation of computer-based computer tomography stratification against outcome models in connective tissue disease-related interstitial lung disease: a patient outcome study","volume":"14","author":"Jacob","year":"2016","journal-title":"BMC Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.resinv.2016.05.004","article-title":"A retrospective cohort study of outcome in systemic sclerosis-associated interstitial lung disease","volume":"54","author":"Okamoto","year":"2016","journal-title":"Respir Investig."},{"key":"B26","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1136\/thoraxjnl-2013-203843","article-title":"Connective tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determinants","volume":"69","author":"Walsh","year":"2014","journal-title":"Thorax."},{"key":"B27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ebiom.2018.01.038","article-title":"Prevalence and effects of emphysema in never-smokers with rheumatoid arthritis interstitial lung disease","volume":"28","author":"Jacob","year":"2018","journal-title":"EBioMedicine."},{"key":"B28","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1183\/09031936.05.00021005","article-title":"Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity","volume":"26","author":"Cottin","year":"2005","journal-title":"Eur Respir J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1093\/rheumatology\/keaa451","article-title":"Pleuroparenchymal fibroelastosis in rheumatic autoimmune diseases: a systematic literature review","volume":"59","author":"Orlandi","year":"2020","journal-title":"Rheumatology."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1902135","DOI":"10.1183\/13993003.02135-2019","article-title":"Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact","volume":"56","author":"Bonifazi","year":"2020","journal-title":"Eur Respir J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s13075-015-0872-2","article-title":"Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis\u2013associated interstitial lung disease trials","volume":"17","author":"Khanna","year":"2015","journal-title":"Arthritis Res Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1002\/art.30467","article-title":"Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the scleroderma lung study placebo group: natural history of lung physiology in SSc-ILD","volume":"63","author":"Khanna","year":"2011","journal-title":"Arthritis Rheum."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N Engl J Med."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.807982\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T15:28:42Z","timestamp":1643297322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.807982\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":33,"alternative-id":["10.3389\/fmed.2021.807982"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.807982","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]},"article-number":"807982"}}